PuSH - Publication Server of Helmholtz Zentrum München

Zeilfelder, U.* ; Frank, O.* ; Sparacio, S.* ; Schön, U. ; Bosch, V.* ; Seifarth, W.* ; Leib-Mösch, C.

The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines.

Gene 390, 175-179 (2007)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Using a versatile and highly sensitive retroviral microarray, we have investigated particle preparations from three different human packaging cell lines harboring retroviral vector systems based on human immunodeficiency virus (HIV) and murine leukemia virus (MLV). 293Rev/Gag/Poli cells inducibly express high titers of HIV-derived particles for packaging of HIV vectors. The Phoenix-GP and the Anjou 65 cell lines constitutively express MLV vector particles. We compared the transcription profiles of human endogenous retroviruses (HERVs) in all cell lines with the HERV sequences present in the particles. In addition, the influence of the transfected vector plasmid on the copackaging of HERVs was investigated. All particle preparations showed a defined pattern of endogenous retroviral sequences that differed from the cellular HERV expression pattern. HERV transcripts were observed in the particle preparations independent of whether a vector construct was coexpressed or not.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.721
0.000
11
11
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Human endogenous retroviruses; HERV; Retroviral vector; Packaging cell line; Copackaging; DNA chip; Microarray; gene therapy
Language english
Publication Year 2007
HGF-reported in Year 2007
ISSN (print) / ISBN 0378-1119
e-ISSN 1879-0038
Journal Gene
Quellenangaben Volume: 390, Issue: 1-2, Pages: 175-179 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-502700-001
PubMed ID 17045761
Scopus ID 33846998968
Erfassungsdatum 2007-06-04